Project Grant R21AI194047
Award Date
6/17/25
Completion Date
5/31/27
Dollars Obligated
$542K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This federal Project Grant award of $631,977 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to generate fundamental mechanistic information that enhances immunological memory and reduces the burden of infectious diseases. The key objectives are to: (I) reveal how caloric restriction can be utilized to enhance pathogen- and vaccine-elicited immunological memory, and (II) lead to the development...
This $256,808 Project Grant award was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Washington. The goal of the research is to better define the molecular mechanisms that cause and perpetuate systemic lupus erythematosus (SLE). The project aims to expand analysis of altered mRNA splicing in SLE neutrophils, understand its relation to disease characteristics, and explore...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $702,511 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Chicago. The grant, awarded on August 15, 2024, will support research using artificial intelligence to study the progression of lupus nephritis, a severe manifestation of systemic lupus erythematosus. The project aims to bridge the understanding of lupus nephritis progression between human and murine...
This federal Project Grant award, valued at $709,019.00 and awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to investigate the role of the FOXP3 isoform in regulating autoantibody production and the development of systemic lupus erythematosus (SLE). The research aims to: 1) determine the impact of the FOXP3E2 isoform on regulatory T cell function and germinal center...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $704,041.00 to the Regents of the University of California at Riverside to investigate sex-dependent innate immune mechanisms in type 2 immunity and obesity. The research aims to 1) study sex differences in macrophage and eosinophil function and their protective role in diet-induced obesity and helminth...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $499,746 to support research aimed at uncovering the genetic and molecular mechanisms that link mitochondrial cristae integrity to T cell-mediated autoimmunity. The research seeks to 1) determine how mitochondrial cristae morphology is regulated in effector T cells, 2) understand the relationship between...
This federal Project Grant award of $425,958.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) will support research to establish the role of glucagon in calorie restriction-induced improvements in health and lifespan. Specifically, the award will fund two aims: Measuring serum glucagon, GLP-1, and FGF21 concentrations, as well as the glucagon-alanine index (a marker of glucagon sensitivity), in participants of the CALERIE trial at baseline, 12 months, and 24 months to...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $558,045 to Beth Israel Deaconess Medical Center, Inc. (Bidmc) to study the role of protein phosphatase 2A (PP2A) in regulating immune cell function and metabolism in systemic lupus erythematosus (SLE). The research aims to determine how PP2A controls enzymes involved in glycolysis and the pentose phosphate pathway,...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research to investigate the role of the aryl hydrocarbon receptor (AhR) pathway in regulating the development of certain B cell subsets associated with systemic lupus erythematosus (SLE). The $555,774 award, effective from November 2024 through October 2029, will enable researchers at the University of...
This federal Project Grant award of $441,202.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support research to investigate the role of ex-regulatory T cells (ex-Tregs) in autoimmunity and cancer immunity. The research aims to utilize a genetic Treg lineage tracing system to monitor ex-Tregs and test whether they are required for tumor control or the onset of autoimmune disease when...